Search - tctmd.com

Displaying 241 - 260 of 1083

Sort: Relevancy | Date

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News LINC 2020

DCBs Show Consistent Long-term Benefits in Complex Fem-Pop Patient Subsets

L.A. McKeown

January 30, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

L.A. McKeown

January 09, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Daily News

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Caitlin E. Cox

December 05, 2019

News Conference News VEITH 2019

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

L.A. McKeown

November 28, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

Advertisement

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

DCBs Show Consistent Long-term Benefits in Complex Fem-Pop Patient Subsets

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

FDA’s First Take on New Paclitaxel Concerns in CLI

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

The Biggest News of 2019: TCTMD’s Top 10

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

FDA Gives Rivaroxaban Another VTE-Related Indication

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content